Skip to content

Apotheek Devroe

Active
Private limited companyfounded 198738 yrs activeKortrijkstraat 129, 8700 Tielt, BelgiumKBO/BCE: BE 0432.762.926
Summary

Apotheek Devroe has been active since 1987 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.65M and a net result of €281k. Equity is growing by ~19% per year across the filed fiscal years. Its solvency ranks better than 51% of 10407 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Checked score

Score 2025
Axes · tick = 2024
Profitability77▼-4
Solvency63▲+6
Growth78=
Track record100
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €110k at 30 days acceptable
Liquidity tight (current ratio 1.38 against 1.03 in 2024; short-term debt: 27.4% and cash: 13.8% of total assets), and 61.7% of the assets are financed with debt.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 38 years 0 40 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
38.3%
Return on assets
6.5%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 21-05-2026, 71 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
71 d early
2024
12 d late
2023
29 d late
2022
17 d early
2021
31 d late
2020
45 d early
2019
31 d late
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

Apotheek Devroe was incorporated on 21 December 1987.1 Total assets rose from EUR 1.3 million in 2018 to EUR 4.3 million in 2025 and headcount from 5.9 to 6.8 full-time equivalents.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Financials · fiscal year 2025, abbreviated schema

Equity
€1.65M▲ 20.5%
2024 · €1.37M
Total assets
€4.29M▲ 1.4%
2024 · €4.23M
Net result
€281k▼ 29.7%
2024 · €399k
Working capital
€451k▲ 1,288%
2024 · €33k
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€152k▲ 21.7%€414k▲ 173%€475k▲ 14.8%€647k▲ 36.1%€524k▼ 18.9%
Net result€25k▼ 74.3%€248k▲ 890%€286k▲ 15.2%€399k▲ 39.8%€281k▼ 29.7%
Equity€626k▼ 17.9%€874k▲ 39.4%€967k▲ 10.7%€1.37M▲ 41.2%€1.65M▲ 20.5%
Total assets€3.52M▲ 15.8%€3.86M▲ 9.5%€4.13M▲ 7.0%€4.23M▲ 2.5%€4.29M▲ 1.4%
Debt€2.90M▲ 27.1%€2.98M▲ 3.1%€3.16M▲ 5.9%€2.87M▼ 9.4%€2.65M▼ 7.6%
Working capital€349k▼ 31.7%€600k▲ 72.2%€-45k€33k€451k▲ 1,288%
Staff (FTE)6.7▼ 2.9%7.4▲ 10.4%8.6▲ 16.2%7.4▼ 14.0%6.8▼ 8.1%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€0€200k€400k€600kOperating result 2021: €152k€152kNet result 2021: €25k€25kOperating result 2022: €414k€414kNet result 2022: €248k€248kOperating result 2023: €475k€475kNet result 2023: €286k€286kOperating result 2024: €647k€647kNet result 2024: €399k€399kOperating result 2025: €524k€524kNet result 2025: €281k€281k20212022202320242025€0€200k€400k€600kOperating result 2023: €475k€475kNet result 2023: €286k€286kOperating result 2024: €647k€647kNet result 2024: €399k€399kOperating result 2025: €524k€524kNet result 2025: €281k€281k202320242025
The operating result falls in 2025; 2025 is 19% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €4.29M
Fixed assets €2.67M ▼ 10.3%
Current assets €1.63M ▲ 29.2%
Equity and liabilities €4.29M
Equity €1.65M ▲ 20.5%
Debt €2.65M ▼ 7.6%
Debt's share of the balance-sheet total falls from 67.7% to 61.7%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€675k▼
2024 · €785k
Cash flow
€431k▼
2024 · €538k
Current ratio
1.38▲
2024 · 1.03
Quick ratio
0.85▲
2024 · 0.58
Debt to equity
1.61▼
2024 · 2.10
ROE
17.1%▼
2024 · 29.2%
ROA
6.5%▼
2024 · 9.4%
Interest coverage
11.19▼
2024 · 11.30
Debt ≤ 1 year
€1.17M▼
2024 · €1.23M
Debt > 1 year
€1.46M▼
2024 · €1.63M
Income taxes
€192k▲
2024 · €186k
Staff costs
€458k▼
2024 · €487k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 60 lines
Balance sheet Code20242025
Assets
Total assets20/58€4.23M€4.29M▲
Fixed assets21/28€2.97M€2.67M▼
Tangible fixed assets22/27€2.69M€2.67M▼
Land and buildings22€2.27M€2.18M▼
Plant, machinery and equipment23€249k€312k▲
Furniture and vehicles24€29k€25k▼
Other tangible fixed assets26-€2k
Assets under construction and advance payments27€147k€147k=
Financial fixed assets28€279k€0▼
Current assets29/58€1.26M€1.63M▲
Stocks and contracts in progress3€551k€631k▲
Stocks30/36€551k€631k▲
Amounts receivable within one year40/41€343k€392k▲
Trade receivables40€300k€314k▲
Other amounts receivable41€43k€79k▲
Cash at bank and in hand54/58€357k€594k▲
Deferred charges and accrued income490/1€8k€8k▼
Equity and liabilities
Total equity and liabilities10/49€4.23M€4.29M▲
Equity10/15€1.37M€1.65M▲
Contributions10/11€21k€21k=
Revaluation surpluses12€3k€3k=
Reserves13€1.34M€1.62M▲
Distributable reserves133€1.34M€1.62M▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€2.87M€2.65M▼
Amounts payable after more than one year17€1.63M€1.46M▼
Financial debts170/4€1.63M€1.46M▼
Amounts payable within one year42/48€1.23M€1.17M▼
Current portion of amounts payable after more than one year42€191k€165k▼
Financial debts43€32k€40k▲
Credit institutions430/8€32k€40k▲
Trade debts44€267k€278k▲
Suppliers440/4€267k€278k▲
Advances received on contracts in progress46€117€709▲
Taxes, remuneration and social security45€171k€178k▲
Taxes450/3€100k€108k▲
Remuneration and social security454/9€71k€70k▼
Other amounts payable47/48€565k€513k▼
Accrued charges and deferred income492/3€12k€10k▼
Income statement Code20242025
Remuneration, social security and pensions62€487k€458k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€138k€150k▲
Other operating charges640/8€10k€10k▲
Non-recurring operating charges66A€477€215k▲
Gross operating margin9900€1.28M€1.36M▲
Operating profit (loss)9901€647k€524k▼
Financial income75/76B€8k€9k▲
Recurring financial income75€8k€9k▲
Financial charges65/66B€69k€60k▼
Recurring financial charges65€69k€60k▼
Profit (loss) for the period before taxes9903€585k€473k▼
Income taxes67/77€186k€192k▲
Profit (loss) for the period9904€399k€281k▼
Profit (loss) for the period to be appropriated9905€399k€281k▼
Appropriation of the result
Profit (loss) to be appropriated9906€399k€281k▼
Transfer from equity791/2€0-
Transfer to equity691/2€399k€280k▼
To other reserves6921€399k€280k▼
Profit to be distributed694/7€867€841▼
Return on contributions (dividend)694€867€841▼
Social balance
Average headcount (FTE)90877.46.8▼

The notes to these accounts (23 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Remuneration, social security and pensions62€383k€419k€486k€487k€458k▼ 5.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€161k€153k€173k€138k€150k▲ 8.7%
Other operating charges640/8€11k€9k€9k€10k€10k▲ 1.8%
Non-recurring operating charges66A€147k€1k€279€477€215k▲ 45,034%
Gross operating margin9900€854k€997k€1.14M€1.28M€1.36M▲ 5.9%
Operating profit (loss)9901€152k€414k€475k€647k€524k▼ 18.9%
Financial income75/76B€6k€7k€11k€8k€9k▲ 3.6%
Recurring financial income75€6k€7k€11k€8k€9k▲ 3.6%
Financial charges65/66B€81k€58k€68k€69k€60k▼ 13.2%
Recurring financial charges65€81k€58k€68k€69k€60k▼ 13.2%
Profit (loss) for the period before taxes9903€77k€363k€418k€585k€473k▼ 19.3%
Income taxes67/77€52k€115k€133k€186k€192k▲ 3.2%
Profit (loss) for the period9904€25k€248k€286k€399k€281k▼ 29.7%
Profit (loss) for the period to be appropriated9905€25k€248k€286k€399k€281k▼ 29.7%
Line20212022202320242025Change
Assets
Total assets20/58€3.52M€3.86M€4.13M€4.23M€4.29M▲ 1.4%
Fixed assets21/28€2.59M€2.48M€2.91M€2.97M€2.67M▼ 10.3%
Tangible fixed assets22/27€2.59M€2.45M€2.64M€2.69M€2.67M▼ 1.0%
Land and buildings22€2.29M€2.21M€2.35M€2.27M€2.18M▼ 3.9%
Plant, machinery and equipment23€274k€227k€273k€249k€312k▲ 25.4%
Furniture and vehicles24€18k€15k€11k€29k€25k▼ 15.1%
Other tangible fixed assets26€0---€2k-
Assets under construction and advance payments27---€147k€147k=
Financial fixed assets28€0€25k€279k€279k€0▼ 100%
Current assets29/58€937k€1.38M€1.21M€1.26M€1.63M▲ 29.2%
Amounts receivable after more than one year29€9k€0----
Other amounts receivable291€9k€0----
Stocks and contracts in progress3€429k€433k€515k€551k€631k▲ 14.7%
Stocks30/36€429k€433k€515k€551k€631k▲ 14.7%
Amounts receivable within one year40/41€281k€271k€401k€343k€392k▲ 14.4%
Trade receivables40€214k€245k€317k€300k€314k▲ 4.6%
Other amounts receivable41€67k€26k€84k€43k€79k▲ 83.8%
Cash at bank and in hand54/58€211k€659k€292k€357k€594k▲ 66.3%
Deferred charges and accrued income490/1€7k€16k€7k€8k€8k▼ 2.1%
Equity and liabilities
Total equity and liabilities10/49€3.52M€3.86M€4.13M€4.23M€4.29M▲ 1.4%
Equity10/15€626k€874k€967k€1.37M€1.65M▲ 20.5%
Contributions10/11€21k€21k€21k€21k€21k=
Revaluation surpluses12€3k€3k€3k€3k€3k=
Reserves13€603k€850k€944k€1.34M€1.62M▲ 20.8%
Non-distributable reserves130/1€2k€0----
Reserves not available under the articles1311€2k€0----
Distributable reserves133€601k€850k€944k€1.34M€1.62M▲ 20.8%
Profit (loss) carried forward14€0€0€0€0€0-
Amounts payable17/49€2.90M€2.98M€3.16M€2.87M€2.65M▼ 7.6%
Amounts payable after more than one year17€2.30M€2.20M€1.90M€1.63M€1.46M▼ 10.1%
Financial debts170/4€2.30M€2.20M€1.90M€1.63M€1.46M▼ 10.1%
Amounts payable within one year42/48€588k€779k€1.26M€1.23M€1.17M▼ 4.2%
Current portion of amounts payable after more than one year42€206k€293k€303k€191k€165k▼ 13.7%
Financial debts43-€52k€13k€32k€40k▲ 27.2%
Credit institutions430/8-€52k€13k€32k€40k▲ 27.2%
Trade debts44€168k€203k€232k€267k€278k▲ 4.0%
Suppliers440/4€168k€203k€232k€267k€278k▲ 4.0%
Advances received on contracts in progress46€160€321€477€117€709▲ 504%
Taxes, remuneration and social security45€74k€102k€161k€171k€178k▲ 3.8%
Taxes450/3€22k€32k€81k€100k€108k▲ 7.2%
Remuneration and social security454/9€52k€70k€80k€71k€70k▼ 1.2%
Other amounts payable47/48€140k€128k€550k€565k€513k▼ 9.2%
Accrued charges and deferred income492/3€7k€7k€6k€12k€10k▼ 17.5%
Line20212022202320242025Change
Profit (loss) for the period9904€25k€248k€286k€399k€281k▼ 29.7%
+ Depreciation and write-downs630€161k€153k€173k€138k€150k▲ 8.7%
Operating cash flow (approximation)€186k€401k€459k€538k€431k▼ 19.8%
Investment in fixed assets (approximation)-€-46k€-608k€-197k€155k▲ 179%
Change in cash-€448k€-367k€65k€237k▲ 263%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
21-05
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
12-08
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema · 12 days late
2024
31-12
Financial Highest result since 2018net €399k ▲39.8%
Operating result €647k, net result €399k, both a record.
31-12
Financial Equity above €1MEq €1.37M ▲41.2%
6 profitable years in a row build equity to €1.37M.
29-08
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema · 29 days late
2023
14-07
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-08
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema · 31 days late
2021
16-06
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-08
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema · 31 days late
2019
31-12
Financial Back to profitnet €373k
Net result €373k after one loss-making year.
31-12
Financial Equity above €500kEq €735k ▲74.2%
Equity rises from €422k to €735k.
21-06
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
31-08
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema · 31 days late
2017
16-10
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema · 77 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts

We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Tielt · 3 establishment units since 1987
seat establishment All 3 establishment units on the map
Ground area
2,406 m²
Building footprint
506 m²
Volume, LiDAR
3,164 m³
3 parcels, Flanders · tallest building 11.4 m, ±3 floors. Linked by address, not a title deed.
5 companies at this address See who is registered here
3 establishment units
Kloosterstraat 16, 8851 Ardooie
Warehousing and support activities for transportation
since 19872.032.143.070
Apotheek Devroe
Kortrijkstraat 129, 8700 TieltRetail trade
since 20092.180.095.883
Apotheek Devroe
Oude Bruggestraat 48, 8750 WingeneRetail trade
since 20112.198.215.087
3 parcels
Flanders 3 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
37018B0848/00Y008 Flanders 1,425 m² 1 · 206 m² 11.3 m · 2 fl.
37005B0215/00K000 Flanders 727 m² 1 · 231 m² 11.4 m · 2 fl.
37303I0447/00P000 Flanders 254 m² 1 · 69 m² 11.0 m · 3 fl.
Linked by address, not proof of ownership
Good to know
3 of 3 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Public money · subsidies and aid

Flemish government

2024 · 1 entry · 295 EUR awarded · 295 EUR paid
Year Entries awardedpaid
2024 1 295 EUR295 EUR
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
1 entry · 295 EUR · 295 EUR paid · Fonds voor Innoveren en Ondernemen

Recognitions · licences · registrations

Food safety, FASFC

3 sites
Ardooie2.032.143.070
1 permission
Apotheek (LM>3 maand) · since 17-12-2014
Tielt2.180.095.883
1 permission
Apotheek (LM>3 maand) · since 17-12-2014
Wingene2.198.215.087
1 permission
Apotheek (LM>3 maand) · since 17-12-2014

Similar companies · same sector, comparable size

Of 5,221 companies in sector 47730 we hold annual accounts for 3,860. 2,581 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded21-12-1987
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products

Scores and ratios are computed by Checked and are not a credit decision.